Wall Street Journal @WSJ reporter covering pharmaceutical industry. Contact me at 215-881-7127, peter.loftus@wsj.com.

New Push Ties Cost of Drugs to How Well They Work

wsj.com — Express Scripts Holding Co., a large manager of prescription-drug benefits for U.S. employers and insurers, is seeking deals with pharmaceutical companies that would set pricing for some cancer drugs based on how well they work.

Actavis Has Discussed Settling Federal Probe of Warner Chilcott Sales Tactics

wsj.com — Drug maker Actavis PLC has held discussions with the Justice Department about resolving an investigation into the marketing tactics at a division, including allegations of improper payments to doctors, according to a regulatory filing and court documents.

Bristol and AbbVie’s Experimental Drug Delayed Blood Cancer Progression, Study Says

wsj.com — Adding an experimental drug co-developed by Bristol-Myers Squibb Co. and AbbVie Inc. to an older treatment for a type of blood cancer delayed disease progression by an average of 4 ½ months in patients in a new clinical trial, researchers said Wednesday.

Amtrak train crashes in Philadelphia, killing at least five people

marketwatch.com — PHILADELPHIA - A northbound Amtrak train headed to New York derailed and crashed here Tuesday night, killing at least five people, Philadelphia Mayor Michael Nutter said. Train 188, which runs along Amtrak's busy Northeast Corridor route, left Washington earlier in the evening. The train was carrying 238 passengers and five crew members, Amtrak said.

Court Blocks Novartis Copy of Amgen Cancer-Care Drug

wsj.com — The U.S. Court of Appeals for the Federal Circuit in Washington on May 5 granted Amgen's request for an injunction blocking Novartis' Zarxio from the U.S. market until the court resolves Amgen's appeal of a lower-court ruling that gave the green light to Zarxio's market entry.

Pfizer, Merck and Bristol-Myers Squibb Report Solid Results

wsj.com — Three major U.S. drug companies reported solid first-quarter results despite a strong dollar, amid signs that their increasing investment in new cancer drugs will be a key driver of Big Pharma's future growth. Pfizer Inc., Merck & Co. and Bristol-Myers Squibb Co.

AbbVie Earnings: What to Watch

blogs.wsj.com — Drug maker AbbVie (ABBV) is scheduled to report its first-quarter 2015 financial results on Thursday before the market opens. Here is what you need to know. EARNINGS FORECAST: Analysts surveyed by Thomson Reuters expect earnings of 85 cents a share, excluding certain items, up from 71 cents a share a year earlier.

Merck’s Keytruda Shows Improved Survival Odds for Melanoma Patients

wsj.com — Merck & Co.'s new cancer drug Keytruda improved the survival odds of patients with the skin cancer melanoma compared with Bristol-Myers Squibb Co.'s Yervoy, in the first head-to-head study of a new wave of drugs that harness the body's immune system to destroy tumors.

What to watch for in Johnson & Johnson earnings

marketwatch.com — By Peter Loftus Health-care giant Johnson & Johnson is scheduled to report its first-quarter 2015 financial results on Tuesday before the market opens. Here is what you need to know. Earnings: Analysts surveyed by Thomson Reuters expect earnings of $1.54 a share, excluding certain items, flat with a year earlier.

What to expect from Johnson & Johnson earnings

marketwatch.com — Health-care giant Johnson & Johnson is scheduled to report its first-quarter 2015 financial results on Tuesday before the market opens. Here is what you need to know: Earnings: Analysts surveyed by Thomson Reuters expect earnings of $1.54 a share, excluding certain items, flat with a year earlier.
More Articles →
May 28, 2015

RT @bradloncar: Cancer immunotherapy stocks are rallying into #ASCO15 just like for #AACR15. But will they sell off after as well? pic.twitter.com/EeCVQ72yBX

May 28, 2015

Teva Close to Settlement of FTC 'Pay-for-Delay' Probe Over Provigil, Valued at Roughly $1 Billion: on.wsj.com/1PPMBab via @WSJ

May 27, 2015

RT @DavePizzi: @SallyAnnWest @WSJ @Loftus True. Perf-based reimbursement is easier said than done..& needed to get past the quantity pay #…

May 27, 2015

RT @SallyAnnWest: @DavePizzi interesting. One issue- everyone responds differently. One persons miracle may have no effect on another. Thoughts? @WSJ @Loftus

May 27, 2015

RT @DrBobGoldberg: .@Loftus After decades of no progress in recurring neck/head carcinoma Erbitux w/ standard chemo hiked survival. How's that worth only $471?

May 27, 2015

The FBI is investigating hysterectomy device found to spread uterine cancer in women on.wsj.com/1KoVoZS via @WSJ $JNJ



Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.

Email

For instructions on how to pitch Peter Loftus, email loftus@muckrack.com.


Share This Profile